Recent Advances in Pediatric Infectious Diseases: A Review of Diagnostic and Therapeutic Strategies

Area of Science:

• Pediatric Infectious Diseases
• Molecular Diagnostics
• Therapeutic Innovations

Background:

• Pediatric infectious diseases cause significant global morbidity and mortality, particularly in children under five.
• Challenges include delayed diagnosis, antimicrobial resistance, and socioeconomic disparities impacting effective management.
• Existing advances in vaccination and antimicrobial therapy are insufficient to overcome these hurdles.

Purpose of the Study:

• To review recent progress in diagnostics and therapeutics for pediatric infectious diseases.
• To highlight innovations that inform antibiotic stewardship and personalize treatment.
• To synthesize advancements for improving global child health outcomes.

Main Methods:

• Review of recent progress in molecular diagnostics (PCR, multiplex assays, NGS).
• Analysis of biomarkers and host gene expression for bacterial vs. viral infection discrimination.
• Exploration of new therapeutic principles (immunomodulatory drugs, personalized medicine) and digital health technologies.

Main Results:

• Molecular diagnostics and biomarkers aid in distinguishing bacterial from viral infections, informing antibiotic stewardship.
• Personalized medicine strategies and immunomodulatory drugs show promise for enhanced treatment outcomes.
• Digital health and telemedicine are transforming access and management, despite ongoing access restrictions.

Conclusions:

• Integrated diagnostic and therapeutic innovations are crucial for advancing pediatric infectious disease care.
• Addressing challenges like limited pediatric trials, cost, and infrastructure is essential for global impact.
• This synthesis provides insights to optimize clinical practice and guide future research for child health.